Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Comparison of the Efficacy and Safety of Escitalopram Plus PS128 to Escitalopram in the Acute Treatment of Patients With Major Depressive Disorder
Conditions
Interventions
Lactobacillus plantarum PS128
Locations
1
Taiwan
Kaohsiung Municipal Kai-Syuan Psychiatric Hospital
Kaohsiung City, Taiwan
Start Date
November 18, 2016
Primary Completion Date
March 4, 2019
Completion Date
September 1, 2019
Last Updated
September 18, 2019
NCT04480918
NCT06732284
NCT06763081
NCT07111169
NCT06748274
NCT07041073
Lead Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions